Berapakah harga Kiromic BioPharma, Inc. (KRBP)

Harga Kiromic BioPharma, Inc. (KRBP) adalah $0.11

Apakah topi pasaran Kiromic BioPharma, Inc. (KRBP)

Cap pasaran Kiromic BioPharma, Inc. (KRBP) adalah $3.62M

Kiromic BioPharma, Inc. (KRBP) Nisbah P/E

Kiromic BioPharma, Inc. is a biotechnology enterprise that harnesses artificial intelligence to advance allogeneic cell therapies. The company's core mission involves crafting multi-indication T-cell treatments, specifically engineered to combat solid tumors by leveraging the innate capabilities of Gamma Delta T cells. Its developmental pipeline includes ALEXIS-ISO-1, an allogeneic gamma delta CAR-T cell therapy targeting Isomesothelin, and ALEXIS-PRO-1, an allogeneic gamma delta chimeric T cell therapy designed to address PD-L1. Supporting its research and development efforts, the company holds licensing agreements with CGA 369 Intellectual Holdings, Inc. and Longwood University, maintains a collaborative partnership for R&D with Molipharma, S.R.L., and has established a strategic alliance with Leon Office (H.K.) Ltd. Founded in 2006, the entity was initially known as Kiromic, Inc. before officially changing its name to Kiromic BioPharma, Inc. in December 2019. Its operations are headquartered in Houston, Texas.

Tahun	Nisbah P/E	Ubah
Tidak cukup data untuk tarikh yang disediakan.

Tahun

Nisbah P/E

Ubah

Tidak cukup data untuk tarikh yang disediakan.

Syarikat	Nisbah P/E	Perbezaan Nisbah P/E	Negara
Vertex Pharmaceuticals Incorporated VRTX.US	29.20	-	US
Argenx SE ARGX.US	30.62	-	NL
Lonza Group AG LONN.SW	-	-	CH
Samsung Biologics Co.,Ltd. 207940.KS	-	-	KR
UCB S.A. UCB.BR	18.38	-	BE

Syarikat

Nisbah P/E

Perbezaan Nisbah P/E

Negara